Locations:
Search IconSearch

Research

cost-effectiveness of epilepsy surgery
July 29, 2020/Neurosciences/Research

Surgery for Drug-Resistant Temporal Lobe Epilepsy Is Cost-Effective in the U.S.

First U.S. cost-effectiveness analysis in decades supports more surgical evaluations

20-NEU-1918414-alzheimer-brain-650×450

Studies of an Alpha-1 Adrenergic Agonist for Alzheimer’s Advance With New NIA Grant

$2 million will enable preclinical dose and efficacy testing of “compound 3”

EEG monitoring
June 30, 2020/COVID-19

Continuous EEG Monitoring Reveals Seizures, Other Abnormalities in COVID-19 Patients

Acute symptomatic seizures detected in five of 22 patients monitored

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Older man with cane
June 11, 2020/Neurosciences/Research

New Study Indicates Neurological Function Deteriorates Quicker in Depressed MS Patients

Depressed patients also have increased odds for new brain lesions on MRI

brain MRI showing central vein sign
June 4, 2020/Neurosciences/Research

Central Vein Sign: Large Study Is Launched to Establish a New Diagnostic Biomarker in MS

Researchers hope it will lead to earlier, more accurate diagnosis

20-NEU-1892170-ischemic-stroke-650×450

Research on tPA Nanoconjugate Aims to Extend Thrombolysis Benefits to More Stroke Patients

$2M NIH grant will help see if dual-action agent lengthens treatment window

20-NEU-1882508_CQD_650x450_combined

Thalamus Is a Prime Target for Neurodegeneration in MS, Study Suggests

Researchers pair postmortem MRI with histopathology to explore thalamic atrophy

20-NEU-1867295-reoperative-epilepsy-surgery_650x450
March 31, 2020/Neurosciences/Research

Long-Term Outcomes of Repeat Epilepsy Surgery: Insights from the Largest Study to Date

Odds of seizure freedom diminish with each additional operation

BackPage 5 of 17Next

Advertisement

Ad